Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

CYANCYANOTECH CORP

OTC · CIK 0000768408
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2833 Medicinal Chemicals & Botanical Products
FY end0331
XBRL facts326

Identity from submissions API

NameCYANOTECH CORP
CIK0000768408
TickersCYAN
ExchangesOTC
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2833 Medicinal Chemicals & Botanical Products
EIN911206026
LEI—
Fiscal year end0331
State of incorporationNV NV
Phone8083261353
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
73-4460 QUEEN KAAHUMANU HWY
SUITE 102
KAILUA KONA
HI
96740
HI
Mailing address
73-4460 QUEEN KAAHUMANU HWY
SUITE 102
KAILUA-KONA
HI
96740
HI

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

No Financialist filing articles yet for this CIK.

SEC filings

870 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-02-13 15-12G FORM 15-12G 0000947871-26-000144 000-14602 26631525 34 12253
2026-02-13 SC 13E3/A AMENDMENT NO. 2 0000947871-26-000143 005-38427 26631305 34 36496
2026-02-03 SC 13E3/A AMENDMENT NO. 1 0000947871-26-000082 005-38427 26594520 34 270065
2026-01-09 SC 13E3 SCHEDULE 13E-3 0000947871-26-000021 005-38427 26525642 34 315661 1 1
2025-11-10 10-Q FORM 10-Q 0001437749-25-034093 000-14602 251466048 34 6127371 1 1
2025-09-16 4 JENNIFER MIYASHIRO ISO 0001437749-25-029152 5242
2025-09-12 3 JENNIFER MIYASHIRO CFO 0001437749-25-028932 16737
2025-09-02 4 FORM 4 DM 0001437749-25-028195 4194
2025-09-02 4 FORM 4 DV 0001437749-25-028193 4170
2025-09-02 4 FORM 4 MD 0001437749-25-028191 8038
2025-09-02 8-K FORM 8-K 1.01,2.03,9.01 0001437749-25-028099 000-14602 251283308 34 171677 1 1
2025-08-22 8-K FORM 8-K 5.02,5.07,8.01 0001437749-25-027547 000-14602 251242129 34 164678 1 1
2025-08-06 10-Q FORM 10-Q 0001437749-25-025070 000-14602 251189407 34 5243984 1 1
2025-07-31 4 FORM 4 0001437749-25-024127 6938
2025-07-31 4 FORM 4 0001437749-25-024125 8450
2025-07-31 4 FORM 4 0001437749-25-024124 8450
2025-07-31 4 FORM 4 0001437749-25-024122 9117
2025-07-31 4 FORM 4 0001437749-25-024120 9108
2025-07-10 ARS ARS 0001437749-25-022474 000-14602 251114745 34 1087879
2025-07-10 DEF 14A FORM DEF 14A 0001437749-25-022469 000-14602 251114733 34 1175854 1 1
2025-06-20 10-K FORM 10-K 0001437749-25-020904 000-14602 251061236 34 8149459 1 1
2025-06-18 4 FORM 4 MC 0001437749-25-020772 7620
2025-05-21 4 FORM 4 JB 0001437749-25-017946 5192
2025-05-21 4 FORM 4 AN 0001437749-25-017944 5206
2025-05-21 4 FORM 4 GJ 0001437749-25-017942 5147
2025-05-20 3 FORM 3 JB 0001437749-25-017803 15333
2025-05-08 8-K FORM 8-K 1.01,2.03,5.02,9.01 0001437749-25-015470 000-14602 25925769 34 265210 1 1
2025-04-09 4 FORM 4 CK 0001437749-25-011538 8471
2025-04-09 4 FORM 4 AN 0001437749-25-011526 8498
2025-04-09 4 FORM 4 JJ 0001437749-25-011521 8498
2025-04-09 4 FORM 4 GJ 0001437749-25-011517 9156
2025-04-09 4 FORM 4 MC 0001437749-25-011515 6892
2025-04-09 4 FORM 4 GC 0001437749-25-011512 9165
2025-02-20 4 FORM 4 CK 0001437749-25-004552 8466
2025-02-20 4 FORM 4 AN 0001437749-25-004547 8551
2025-02-20 4 FORM 4 JJ 0001437749-25-004544 8551
2025-02-20 4 FORM 4 GJ 0001437749-25-004540 9208
2025-02-20 4 FORM 4 GC 0001437749-25-004537 9217
2025-02-11 10-Q FORM 10-Q 0001437749-25-003413 000-14602 25609681 34 5995306 1 1
2024-12-16 8-K FORM 8-K 4.01,9.01 0001437749-24-037557 000-14602 241551233 34 161245 1 1
2024-11-12 10-Q FORM 10-Q 0001437749-24-034529 000-14602 241447773 34 5931360 1 1
2024-10-03 SC 13D/A cyan13da13.htm 0000935836-24-000620 005-38427 241353001 34 90669
2024-10-03 4 FORM 4 MD 0001437749-24-030594 10238
2024-10-01 4 FORM 4 MD 0001437749-24-030360 9810
2024-09-27 4 FORM 4 MD 0001437749-24-030159 9810
2024-09-25 4 FORM 4 MD 0001437749-24-029976 9810
2024-09-23 4 FORM 4 MD 0001437749-24-029826 9810
2024-09-19 4 FORM 4 MD 0001437749-24-029606 11404
2024-09-17 4 FORM 4 MD 0001437749-24-029379 9810
2024-09-13 4 FORM 4 MD 0001437749-24-029151 9810
2024-09-12 SC 13D/A cyan13da12.htm 0000935836-24-000585 005-38427 241294378 34 89939
2024-09-11 4 FORM 4 MD 0001437749-24-028990 11972
2024-09-09 4 FORM 4 RJ 0001437749-24-028769 5226
2024-09-09 3 FORM 4 JR 0001437749-24-028760 12874
2024-09-09 4 FORM 4 MD 0001437749-24-028752 9810
2024-09-06 SC 13D/A cyan13da11.htm 0000935836-24-000580 005-38427 241283698 34 89885
2024-09-05 4 FORM 4 DV 0001437749-24-028580 4179
2024-09-05 4 FORM DM 0001437749-24-028578 4201
2024-09-05 4 FORM 4 MD 0001437749-24-028576 11364
2024-09-03 4 FORM 4 MD 0001437749-24-028241 11404
2024-08-29 4 FORM 4 MD 0001437749-24-028041 9810
2024-08-27 4 FORM 4 0001437749-24-027840 9807
2024-08-23 4 FORM 4 MD 0001437749-24-027653 9810
2024-08-23 8-K FORM 8-K 5.02,5.07,8.01 0001437749-24-027650 000-14602 241235645 34 160274 1 1
2024-08-21 4 FORM 4 0001437749-24-027464 9807
2024-08-19 4 FORM 4 MD 0001437749-24-027200 9810
2024-08-15 SC 13D/A cyan13da10.htm 0000935836-24-000531 005-38427 241213781 34 89424
2024-08-15 4 FORM 4 MD 0001437749-24-027002 9810
2024-08-13 8-K FORM 8-K 1.01,2.03,9.01 0001437749-24-026409 000-14602 241201886 34 174129 1 1
2024-08-13 4 FORM 4 MD 0001437749-24-026342 9810
2024-08-09 4 FORM 4 MD 0001437749-24-025833 9810
2024-08-07 10-Q FORM 10-Q 0001437749-24-025171 000-14602 241183458 34 5067131 1 1
2024-08-07 4 FORM 4 0001437749-24-025135 9807
2024-08-05 4 FORM 4 MD 0001437749-24-024634 9810
2024-08-01 4 FORM 4 MD 0001437749-24-024267 9810
2024-07-31 4 FORM 4 AN 0001437749-24-024135 8580
2024-07-31 4 FORM 4 FL 0001437749-24-024130 8552
2024-07-31 4 FORM 4 JJ 0001437749-24-024120 8579
2024-07-31 4 FORM 4 GJ 0001437749-24-024112 9237
2024-07-31 4 FORM 4 CJH 0001437749-24-024106 8581
2024-07-31 4 FORM 4 GC 0001437749-24-024101 9246
2024-07-31 4 FORM 4 MC 0001437749-24-024095 8567
2024-07-30 4 FORM 4 MD 0001437749-24-023939 9810
2024-07-26 4 FORM 4 MD 0001437749-24-023601 9810
2024-07-26 SC 13D/A cyan13da9.htm 0000935836-24-000493 005-38427 241146036 34 89239
2024-07-24 4 FORM 4 0001437749-24-023336 9807
2024-07-22 4 FORM 4 0001437749-24-023158 9807
2024-07-18 4 FORM 4 MD 0001437749-24-022975 9810
2024-07-16 4 FORM 4 MD 0001437749-24-022838 9811
2024-07-12 4 FORM 4 MD 0001437749-24-022640 9810
2024-07-11 ARS ARS 0001437749-24-022517 000-14602 241110990 34 942914
2024-07-11 DEF 14A FORM DEF 14A 0001437749-24-022515 000-14602 241110985 34 456585
2024-07-10 4 FORM 4 MD 0001437749-24-022445 9810
2024-07-08 4 FORM 4 MD 0001437749-24-022283 9810
2024-06-28 PRE 14A FORM PRE 14A 0001437749-24-021520 000-14602 241084220 34 479058
2024-06-26 10-K FORM 10-K 0001437749-24-021266 000-14602 241073395 34 8873961 1 1
2024-04-10 4 FORM 4 CJH 0001437749-24-011688 8601
2024-04-10 4 FORM 4 JJ 0001437749-24-011686 8599
2024-04-10 4 FORM 4 AN 0001437749-24-011684 8599
2024-04-10 4 FORM 4 GJ 0001437749-24-011682 9257
2024-04-10 4 FORM 4 FL 0001437749-24-011678 8572
2024-04-10 4 FORM 4 MC 0001437749-24-011676 8587
2024-04-10 4 FORM 4 GC 0001437749-24-011674 9266
2024-04-09 25-NSE xslF25X02/primary_doc.xml 0001354457-24-000253 000-14602 34 3760
2024-02-27 4 FORM 4 GJ 0001437749-24-005693 6400
2024-02-21 4 FORM 4 FL 0001437749-24-004961 8618
2024-02-21 4 FORM 4 GC 0001437749-24-004959 9312
2024-02-21 4 FORM 4 GJ 0001437749-24-004957 9301
2024-02-21 4 FORM 4 JJ 0001437749-24-004955 8645
2024-02-21 4 FORM 4 CK 0001437749-24-004953 8505
2024-02-21 4 FORM 4 CJH 0001437749-24-004950 8647
2024-02-21 4 FORM 4 AN 0001437749-24-004948 8645
2024-02-14 8-K FORM 8-K 3.01 0001437749-24-004144 000-14602 24637547 34 166415 1 1
2024-02-08 10-Q FORM 10-Q 0001437749-24-003511 000-14602 24608927 34 5729636 1 1
2023-12-20 SC 13D/A cyan13da.htm 0000935836-23-000734 005-38427 231500452 34 90250
2023-12-19 4 FORM 4 MD 0001437749-23-034899 8048
2023-12-19 8-K FORM 8-K 3.02,9.01 0001437749-23-034882 000-14602 231497215 34 262770 1 1
2023-12-04 4 FORM 4 MD 0001437749-23-033491 7967
2023-11-08 10-Q FORM 10-Q 0001437749-23-030927 000-14602 231387677 34 5426339 1 1
2023-10-17 4 FORM 4 MD 0001437749-23-028357 8470
2023-09-18 4 FORM 4 MD 0001437749-23-026160 8538
2023-09-14 4 FORM 4 CK 0001437749-23-025917 5154
2023-09-14 4 FORM 4 MD 0001437749-23-025914 10339
2023-09-12 4 FORM 4 MD 0001437749-23-025725 10260
2023-09-08 4 FORM 4 MD 0001437749-23-025519 10338
2023-09-07 4 FORM 4 MD 0001437749-23-025387 10338
2023-09-01 3 FORM 3 CK 0001437749-23-025069 19093
2023-08-30 SC 13D/A cyan13da-a1.htm 0000935836-23-000600 005-38427 231224167 34 48669
2023-08-29 8-K FORM 8-K 5.07,8.01 0001437749-23-024847 000-14602 231222773 34 172343 1 1
2023-08-29 SC 13D/A cyan13da.htm 0000935836-23-000599 005-38427 231222597 34 116314
2023-08-29 SC 13D cyan13d.htm 0000935836-23-000598 005-38427 231222349 34 63341
2023-08-28 4 FORM 4 AM 0001437749-23-024761 4148
2023-08-28 4 FORM 4 DM 0001437749-23-024758 4121
2023-08-28 4 FORM 4 DV 0001437749-23-024756 4097
2023-08-28 4 FORM 4 MD 0001437749-23-024754 10059
2023-08-17 8-K FORM 8-K 1.01,2.03,9.01 0001437749-23-024061 000-14602 231181800 34 174139 1 1
2023-08-11 8-K FORM 8-K 3.01 0001437749-23-023349 000-14602 231164827 34 161201 1 1
2023-08-11 10-Q FORM 10-Q 0001437749-23-023314 000-14602 231163902 34 4811170 1 1
2023-08-01 4 FORM 4 AN 0001437749-23-021390 8522
2023-08-01 4 FORM 4 CJH 0001437749-23-021386 8524
2023-08-01 4 FORM 4 JJ 0001437749-23-021384 8522
2023-08-01 4 FORM 4 GJ 0001437749-23-021381 9178
2023-08-01 4 FORM 4 FL 0001437749-23-021377 8494
2023-08-01 4 FORM 4 MC 0001437749-23-021372 8545
2023-08-01 4 FORM 4 GC 0001437749-23-021368 9189
2023-07-14 ARS ANNUAL REPORT 0001437749-23-019915 000-14602 231088003 34 887405
2023-07-14 DEF 14A FORM DEF 14A 0001437749-23-019912 000-14602 231087980 34 434983
2023-07-05 8-K FORM 8-K 8.01 0001437749-23-019355 000-14602 231068673 34 156334 1 1
2023-06-27 10-K FORM 10-K 0001437749-23-018616 000-14602 231047314 34 9179601 1 1
2023-06-16 8-K FORM 8-K 8.01 0001437749-23-017678 000-14602 231020760 34 139575 1 1
2023-05-08 8-K FORM 8-K 3.01 0001437749-23-013008 000-14602 23897578 34 163847 1 1
2023-04-10 4 FORM 4 AN 0001437749-23-009825 10982
2023-04-10 4 FORM 4 CJH 0001437749-23-009822 10922
2023-04-10 4 FORM 4 JJ 0001437749-23-009820 10982
2023-04-10 4 FORM 4 GJ 0001437749-23-009817 11638
2023-04-10 4 FORM 4 FL 0001437749-23-009815 10893
2023-04-10 4 FORM 4 MC 0001437749-23-009813 11006
2023-04-10 4 FORM 4 GC 0001437749-23-009811 11649
2023-04-04 4 FORM 4 MD 0001437749-23-009262 9733
2023-04-04 4 FORM 4 DV 0001437749-23-009260 4592
2023-02-09 10-Q FORM 10-Q 0001437749-23-002878 000-14602 23606107 34 5454018 1 1
2022-12-19 8-K FORM 8-K 1.01,2.03,9.01 0001437749-22-029352 000-14602 221471048 34 178034 1 1
2022-11-09 10-Q FORM 10-Q 0001437749-22-026580 000-14602 221372437 34 5406908 1 1
2022-09-01 4 FORM 4 WM 0001437749-22-021686 4513
2022-09-01 4 FORM 4 AM 0001437749-22-021682 4116
2022-09-01 4 FORM 4 DV 0001437749-22-021678 4064
2022-09-01 4 FORM 4 DM 0001437749-22-021676 4088
2022-09-01 4 FORM 4 MD 0001437749-22-021674 9239
2022-08-30 8-K FORM 8-K 5.07 0001437749-22-021466 000-14602 221212752 34 161134 1 1
2022-08-10 10-Q FORM 10-Q 0001437749-22-019787 000-14602 221151751 34 4753982 1 1
2022-08-02 4 FORM 4 CJH 0001437749-22-018421 5264
2022-08-02 4 FORM 4 AN 0001437749-22-018417 10849
2022-08-02 4 FORM 4 JJ 0001437749-22-018411 10849
2022-08-02 4 FORM 4 FL 0001437749-22-018407 5211
2022-08-02 4 FORM 4 GJ 0001437749-22-018405 11505
2022-08-02 4 FORM 4 GC 0001437749-22-018400 11516
2022-08-02 4 FORM 4 MC 0001437749-22-018395 10870
2022-07-18 DEF 14A FORM DEF 14A 0001437749-22-017217 000-14602 221087881 34 377813
2022-06-22 4 FORM 4 MC 0001437749-22-015622 5106
2022-06-22 10-K FORM 10-K 0001437749-22-015612 000-14602 221032580 34 8529744 1 1
2022-06-22 8-K FORM 8-K 1.01,5.02,9.01 0001437749-22-015606 000-14602 221032244 34 239229 1 1
2022-04-08 4 FORM 4 CJH 0001437749-22-008591 8339
2022-04-08 4 FORM 4 AN 0001437749-22-008587 8417
2022-04-08 4 FORM 4 JJ 0001437749-22-008585 8418
2022-04-08 4 FORM 4 MC 0001437749-22-008583 8394
2022-04-08 4 FORM 4 GJ 0001437749-22-008581 9074
2022-04-08 4 FORM 4 FL 0001437749-22-008579 8309
2022-04-08 4 FORM 4 GC 0001437749-22-008576 9113
2022-02-10 10-Q FORM 10-Q 0001437749-22-002997 000-14602 22613832 34 5673211 1 1
2021-12-01 4 FORM 4 MD 0001437749-21-027637 10819
2021-11-16 3 FORM 3 AM 0001437749-21-026831 12447
2021-11-10 10-Q FORM 10-Q 0001437749-21-026134 000-14602 211396406 34 5819823 1 1
2021-11-10 8-K FORM 8-K 5.02 0001437749-21-025975 000-14602 211393581 34 157669 1 1
2021-10-20 4 FORM 4 NK 0001437749-21-023969 4120
2021-10-20 4 FORM 4 WM 0001437749-21-023967 4102
2021-10-20 4 FORM 4 DV 0001437749-21-023963 4064
2021-10-20 4 FORM 4 DM 0001437749-21-023959 4088
2021-10-20 4 FORM 4 MD 0001437749-21-023957 9239
2021-08-31 8-K FORM 8-K 5.07 0001437749-21-021216 000-14602 211224987 34 165154 1 1
2021-08-11 10-Q FORM 10-Q 0001437749-21-019444 000-14602 211163427 34 5098218 1 1
2021-08-03 4 FORM 4 MC 0001437749-21-018406 6803
2021-08-03 4 FORM 4 AN 0001437749-21-018404 8458
2021-08-03 4 FORM 4 JJ 0001437749-21-018402 8441
2021-08-03 4 FORM 4 GJ 0001437749-21-018400 7482
2021-08-03 4 FORM 4 GC 0001437749-21-018398 9148
2021-07-30 3 FORM 3 CJH 0001437749-21-018022 19879
2021-07-15 4 FORM 4 MC 0001437749-21-017025 6831
2021-07-15 4 FORM 4 AN 0001437749-21-017023 6857
2021-07-15 4 FORM 4 JJ 0001437749-21-017021 8470
2021-07-15 4 FORM 4 GJ 0001437749-21-017019 9125
2021-07-15 4 FORM 4 GC 0001437749-21-017017 9177
2021-07-15 DEF 14A FORM DEF 14A 0001437749-21-016950 000-14602 211091604 34 512479
2021-06-22 10-K FORM 10-K 0001437749-21-015361 000-14602 211035213 34 8304774 1
2021-05-25 4 FORM 4 MC 0001437749-21-013274 5055
2021-05-25 8-K FORM 8-K 5.02 0001437749-21-013264 000-14602 21960058 34 20723
2021-04-16 8-K FORM 8-K 1.01,2.03,9.01 0001437749-21-009066 000-14602 21829696 34 216033
2021-04-08 4 FORM 4 MC 0001437749-21-008580 6870
2021-04-08 4 FORM 4 AN 0001437749-21-008578 6881
2021-04-08 4 FORM 4 JJ 0001437749-21-008574 8492
2021-04-08 4 FORM 4 GJ 0001437749-21-008569 9147
2021-04-08 4 FORM 4 GC 0001437749-21-008562 9199
2021-04-02 SC 13D/A SCHEDULE 13D 0001096906-21-000673 005-38427 21800015 34 107579
2021-03-18 4 FORM 4 GJ 0001437749-21-006448 8531
2021-03-16 4 FORM 4 JJ 0001437749-21-006230 7877
2021-03-10 SC 13G/A wf_cyanotechc-232437301x.htm 0000072971-21-000201 005-38427 21728696 34 18157
2021-02-11 10-Q FORM 10-Q 0001437749-21-002584 000-14602 21619500 34 5311361 1
2020-12-02 SC 13D/A SCHEDULE 13D/A 0001437749-20-024725 005-38427 201364855 34 431794
2020-11-25 4 FORM 4 MD 0001437749-20-024485 10037
2020-11-25 4 FORM 4 WM 0001437749-20-024483 4105
2020-11-12 10-Q FORM 10-Q 0001437749-20-023607 000-14602 201306478 34 5249164 1
2020-10-21 3 FORM 3 FL 0001437749-20-021426 16751
2020-10-01 8-K FORM 8-K 5.02,9.01 0001437749-20-020587 000-14602 201215648 34 112988
2020-09-11 4 FORM 4 MD 0001437749-20-019613 14232
2020-09-09 4 FORM 4 MD 0001437749-20-019490 14397
2020-09-04 4 FORM 4 MD 0001437749-20-019343 10819
2020-09-02 4 FORM 4 MD 0001437749-20-019216 14399
2020-08-31 4 FORM 4 DV 0001437749-20-019018 4064
2020-08-31 4 FORM 4 DM 0001437749-20-019016 4088
2020-08-31 4 FORM 4 NK 0001437749-20-019014 4120
2020-08-31 4 FORM 4 WM 0001437749-20-019012 4102
2020-08-31 4 FORM 4 MD 0001437749-20-019010 7609
2020-08-31 8-K FORM 8-K 5.07 0001437749-20-018975 000-14602 201149690 34 30176
2020-08-12 4 FORM 4 MC 0001437749-20-017696 5101
2020-08-12 4 FORM 4 AN 0001437749-20-017694 5112
2020-08-11 10-Q FORM 10-Q 0001437749-20-017511 000-14602 201092386 34 4690509 1
2020-08-03 4 FORM 4 AN 0001437749-20-016343 5348
2020-08-03 4 FORM 4 MC 0001437749-20-016340 5337
2020-08-03 4 FORM 4 BO 0001437749-20-016338 5304
2020-08-03 4 FORM 4 JJ 0001437749-20-016336 5348
2020-08-03 4 FORM 4 0001437749-20-016333 5302
2020-08-03 4 FORM 4 GC 0001437749-20-016330 5343
2020-07-15 4 FORM 4 AN 0001437749-20-015224 6825
2020-07-15 4 FORM 4 MC 0001437749-20-015222 8425
2020-07-15 4 FORM 4 JJ 0001437749-20-015220 8439
2020-07-15 4 FORM 4 GJ 0001437749-20-015218 9094
2020-07-15 4 FORM 4 GC 0001437749-20-015216 9152
2020-07-15 DEF 14A FORM DEF 14A 0001437749-20-015147 000-14602 201028378 34 386712
2020-06-23 10-K FORM 10-K 0001437749-20-013699 000-14602 20983238 34 8446600 1
2020-05-11 8-K FORM 8-K 1.01,2.03,9.01 0001437749-20-010307 000-14602 20865211 34 103758
2020-04-09 4 FORM 4 0001437749-20-007414 8455
2020-04-09 4 FORM 4 0001437749-20-007412 8448
2020-04-08 4 FORM 4 0001437749-20-007350 21979
2020-04-08 4 FORM 4 0001437749-20-007348 25289
2020-04-08 4 FORM 4 0001437749-20-007346 22047
2020-04-08 4 FORM 4 0001437749-20-007344 23667
2020-02-20 4 FORM 4 0001437749-20-003218 14020
2020-02-20 4 FORM 4 0001437749-20-003209 23688
2020-02-20 4 FORM 4 0001437749-20-003205 20168
2020-02-20 4 FORM 4 0001437749-20-003203 20139
2020-02-20 4 FORM 4 0001437749-20-003201 20144
2020-02-11 10-Q FORM 10-Q 0001437749-20-002306 000-14602 20596529 34 5250569 1
2020-02-04 SC 13G wf_cyanotechc-232437301.htm 0000072971-20-000143 005-38427 20573784 34 27840
2019-11-12 4 FORM 4 0001437749-19-022492 9049
2019-11-12 10-Q FORM 10-Q 0001437749-19-022447 000-14602 191209204 34 5208785 1
2019-11-08 3 FORM 3 0001437749-19-022187 19471
2019-11-08 3 FORM 3 0001437749-19-022185 18489
2019-10-17 4 FORM 4 0001437749-19-020192 22386
2019-09-23 4 FORM 4 0001437749-19-018915 8992
2019-08-27 4 FORM 4 0001437749-19-017508 8992
2019-08-27 8-K FORM 8-K 5.07 0001437749-19-017475 000-14602 191053864 34 36112
2019-08-13 10-Q FORM 10-Q 0001437749-19-016583 000-14602 191021341 34 4606122 1
2019-08-02 4 FORM 4 0001437749-19-015293 12477
2019-08-02 4 FORM 4 0001437749-19-015291 13002
2019-08-02 4 FORM 4 0001437749-19-015289 12636
2019-07-31 4 FORM 4 0001437749-19-015054 13983
2019-07-10 4 FORM 4 0001437749-19-013768 6607
2019-07-10 DEF 14A FORM DEF 14A 0001437749-19-013751 000-14602 19949380 34 422080
2019-07-01 10-K FORM 10-K 0001437749-19-013217 000-14602 19933215 34 8406290 1
2019-06-07 8-K FORM 8-K 1.01,1.02,5.02,9.01 0001437749-19-011624 000-14602 19886716 34 93857
2019-04-26 8-K FORM 8-K 5.02 0001437749-19-008075 000-14602 19772927 34 17744
2019-04-12 8-K FORM 8-K 1.01,2.03,9.01 0001437749-19-007116 000-14602 19747116 34 49379
2019-04-08 4 FORM 4 0001437749-19-006761 11051
2019-04-08 4 FORM 4 0001437749-19-006759 9328
2019-04-08 4 FORM 4 0001437749-19-006757 10892
2019-04-08 4 FORM 4 0001437749-19-006755 13033
2019-04-03 4 FORM 4 0001437749-19-006498 12075
2019-03-13 SC 13D/A SCHEDULE 13D/A 0001437749-19-004712 005-38427 19676995 34 185382
2019-03-08 4 FORM 4 0001437749-19-004496 7606
2019-03-06 4 FORM 4 0001437749-19-004175 16998
2019-03-05 4 FORM 4 0001437749-19-004129 16619
2019-03-05 4 FORM 4 0001437749-19-004123 7608
2019-03-01 4 FORM 4 0001437749-19-003712 17727
2019-02-28 4 FORM 4 0001437749-19-003650 9160
2019-02-27 SC 13D/A SCHEDULE 13D/A 0001437749-19-003497 005-38427 19638462 34 250800
2019-02-27 4 FORM 4 0001437749-19-003475 17730
2019-02-26 4 FORM 4 0001437749-19-003431 9156
2019-02-25 4 FORM 4 0001437749-19-003286 17728
2019-02-22 4 FORM 4 0001437749-19-003173 9154
2019-02-20 4 FORM 4 0001437749-19-002982 13810
2019-02-13 10-Q FORM 10-Q 0001437749-19-002456 000-14602 19597020 34 4696685 1
2019-01-22 SC 13G/A wf_cyanotechc-232437301.htm 0000072971-19-000109 005-38427 19534633 34 27846
2019-01-11 4 FORM 4 0001437749-19-000717 5105
2019-01-11 3 FORM 3 0001437749-19-000715 12734
2019-01-09 8-K FORM 8-K 5.02,8.01,9.01 0001437749-19-000574 000-14602 19517357 34 146263
2018-12-12 4 FORM 4 0001437749-18-021946 9160
2018-12-07 4 FORM 4 0001437749-18-021756 9160
2018-12-07 8-K FORM 8-K 1.01,9.01 0001437749-18-021753 000-14602 181223959 34 286353
2018-12-03 4 FORM 4 0001437749-18-021514 9159
2018-11-27 4 FORM 4 0001437749-18-021314 7607
2018-11-19 4 FORM 4 0001437749-18-021098 9160
2018-11-13 10-Q FORM 10-Q 0001437749-18-020377 000-14602 181175157 34 4372867 1
2018-11-09 4 OWNERSHIP DOCUMENT 0001445866-18-001201 11301
2018-11-08 SC 13D/A SCHEDULE 13D/A 0001445866-18-001193 005-38427 181169189 34 888991
2018-11-06 SC 13D/A SCHEDULE 13D/A 0001445866-18-001189 005-38427 181162193 34 116403
2018-11-06 8-K FORM 8-K 5.02,9.01 0001437749-18-019578 000-14602 181161345 34 70267
2018-10-31 SC 13D/A SCHEDULE 13D/A 0001445866-18-001164 005-38427 181149163 34 123581
2018-10-29 SC 13D SCHEDULE 13D 0001445866-18-001160 005-38427 181143221 34 105136
2018-10-19 SC 13D/A SCHEDULE 13D/A 0001437749-18-018500 005-38427 181130492 34 283058
2018-09-07 8-K FORM 8-K 8.01 0001437749-18-016716 000-14602 181060183 34 42340
2018-08-29 4 FORM 4 0001437749-18-016358 4113
2018-08-29 4 FORM 4 0001437749-18-016357 5362
2018-08-29 4 FORM 4 0001437749-18-016356 5339
2018-08-29 4 FORM 4 0001437749-18-016355 5377
2018-08-29 4 FORM 4 0001437749-18-016354 8339
2018-08-29 8-K FORM 8-K 5.07 0001437749-18-016286 000-14602 181042755 34 30206
2018-08-13 10-Q FORM 10-Q 0001437749-18-015344 000-14602 181012283 34 4465016 1
2018-07-18 4 FORM 4 0001437749-18-013432 14459
2018-07-18 4 FORM 4 0001437749-18-013430 9634
2018-07-18 4 FORM 4 0001437749-18-013426 14833
2018-07-18 4 FORM 4 0001437749-18-013418 9824
2018-07-18 4 FORM 4 0001437749-18-013415 8681
2018-07-18 4 FORM 4 0001437749-18-013411 15566
2018-07-09 DEF 14A FORM DEF 14A 0001437749-18-013071 000-14602 18943411 34 398956
2018-06-21 10-K/A FORM 10-K/A 0001437749-18-012219 000-14602 18911580 34 7140159 1
2018-06-15 10-K FORM 10-K 0001437749-18-011915 000-14602 18902896 34 7687803 1
2018-04-13 8-K FORM 8-K 8.01 0001437749-18-006874 000-14602 18754924 34 21973
2018-04-09 4 FORM 4 0001437749-18-006546 16700
2018-04-09 4 FORM 4 0001437749-18-006543 9153
2018-04-09 4 FORM 4 0001437749-18-006541 9809
2018-04-09 4 FORM 4 0001437749-18-006538 15966
2018-04-09 4 FORM 4 0001437749-18-006535 8142
2018-04-09 4 FORM 4 0001437749-18-006533 15759
2018-04-04 4 FORM 4 0001437749-18-006320 15798
2018-02-23 4 FORM 4 0001437749-18-003225 15049
2018-02-14 SC 13D SCHEDULE 13D 0001445866-18-000161 005-38427 18609932 34 503162
2018-02-06 10-Q FORM 10-Q 0001437749-18-001823 000-14602 18578452 34 4781731 1
2018-01-29 SC 13G/A wf_cyanotechc-232437301.htm 0000072971-18-000162 005-38427 18554422 34 27846
2018-01-25 8-K FORM 8-K 1.01,5.02,8.01,9.01 0001437749-18-001093 000-14602 18546338 34 80126
2018-01-24 4 FORM 4 0001437749-18-001095 6541
2018-01-05 4 FORM 4 0001437749-18-000320 16448
2017-11-06 10-Q FORM 10-Q 0001437749-17-018407 000-14602 171179525 34 4568781 1
2017-11-06 4/A FORM 4/A 0001437749-17-018397 5727
2017-10-31 4/A FORM 4/A 0001437749-17-017950 8688
2017-10-31 4/A FORM 4/A 0001437749-17-017946 5689
2017-10-31 4/A FORM 4/A 0001437749-17-017944 5713
2017-10-31 4/A FORM 4/A 0001437749-17-017942 4461
2017-08-29 4 FORM 4 0001437749-17-015412 5020
2017-08-29 3 FORM 3 0001437749-17-015410 15381
2017-08-25 8-K FORM 8-K 5.07 0001437749-17-015332 000-14602 171052325 34 32771
2017-08-25 4 FORM 4 0001437749-17-015328 5339
2017-08-25 4 FORM 4 0001437749-17-015327 5363
2017-08-25 4 FORM 4 0001437749-17-015325 5377
2017-08-25 4 FORM 4 0001437749-17-015324 4112
2017-08-25 4 FORM 4 0001437749-17-015322 8339
2017-08-23 4 FORM 4 0001437749-17-015204 8757
2017-08-10 10-Q FORM 10-Q 0001437749-17-014410 000-14602 171021442 34 4245009 1
2017-08-01 SC 13D/A SCHEDULE 13D/A 0001445866-17-001126 005-38427 17997316 34 138057
2017-07-17 8-K FORM 8-K 1.01,5.02,8.01,9.01 0001437749-17-012730 000-14602 17968035 34 109888 1 1
2017-07-07 DEF 14A FORM DEF 14A 0001437749-17-012355 000-14602 17954448 34 394971
2017-06-22 10-K FORM 10-K 0001437749-17-011716 000-14602 17925579 34 7625897 1
2017-04-11 8-K FORM 8-K 1.01 0001437749-17-006451 000-14602 17756543 34 61479
2017-04-07 4 FORM 4 0001437749-17-006274 8363
2017-04-06 4 FORM 4 0001437749-17-006230 14259
2017-04-05 4/A FORM 4/A 0001437749-17-006186 12867
2017-04-05 4 FORM 4 0001437749-17-006180 12788
2017-03-17 SC 13D/A sc13da.htm 0001493152-17-002565 005-38427 17698906 34 326174
2017-03-15 8-K FORM 8-K 1.01 0001437749-17-004587 000-14602 17691260 34 121167
2017-02-16 8-K FORM 8-K 8.01 0001437749-17-002684 000-14602 17618163 34 16018
2017-02-15 SC 13D/A SC 13 D/A 0001445866-17-000157 005-38427 17613637 34 166029
2017-02-07 10-Q FORM 10-Q 0001437749-17-001860 000-14602 17579522 34 4095372 1
2017-01-23 SC 13D/A SC 13D/A 0001445866-17-000062 005-38427 17540305 34 383296
2017-01-19 SC 13D/A SC 13D/A 0001445866-17-000046 005-38427 17535327 34 156315
2017-01-17 SC 13D/A SC 13D/A 0001445866-17-000040 005-38427 17530268 34 263753
2017-01-09 SC 13G/A wf_cyanotechc-232437301.htm 0000072971-17-000006 005-38427 17517830 34 27840
2016-12-20 SC 13D/A sc13da.htm 0001493152-16-016041 005-38427 162061089 34 178733
2016-12-19 8-K FORM 8-K 5.07 0001437749-16-043491 000-14602 162057471 34 19384
2016-12-16 4 FORM 4 0001437749-16-043493 10368
2016-11-10 S-8 FORM S-8 0001437749-16-041776 333-214572 161989268 33 159740
2016-11-10 10-Q FORM 10-Q 0001437749-16-041673 000-14602 161986136 34 4576824 1
2016-11-04 DEF 14A FORM DEF 14A 0001437749-16-041075 000-14602 161973655 34 223918

Latest XBRL company facts

One latest value per concept from companyfacts (326 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 7.39M 2025-11-01 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
dei EntityPublicFloat Entity Public Float USD 2.98M 2024-09-30 2025 FY 10-K 2025-06-20 0001437749-25-020904
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 2.97M 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 2.35M 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap AccruedBonusesCurrent Accrued Bonuses, Current USD 0 2024-03-31 2024 FY 10-K 2024-06-26 0001437749-24-021266
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 920,000 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap AccruedMarketingCostsCurrent Accrued Marketing Costs, Current USD 74,000 2016-03-31 2017 FY 10-K 2017-06-22 0001437749-17-011716
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 136,000 2016-12-31 2017 Q3 10-Q 2017-02-07 0001437749-17-001860
us-gaap AccruedRentCurrent Accrued Rent, Current USD 72,000 2013-12-31 2013 Q3 10-Q 2014-02-06 0001104659-14-007141
us-gaap AccruedSalariesCurrent Accrued Salaries, Current USD 251,000 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap AccruedVacationCurrent Accrued Vacation, Current USD 346,000 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 29.56M 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 34.95M 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 30.35M 2014-09-30 2015 Q2 10-Q 2014-11-13 0001437749-14-020667
us-gaap AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation Share-based Payment Arrangement, Decrease for Tax Withholding Obligation USD 3,000 2025-04-01 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 74,000 2025-04-01 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap AdvertisingExpense Advertising Expense USD 1.12M 2024-04-01 2025-03-31 2025 FY 10-K 2025-06-20 0001437749-25-020904
us-gaap AllowanceForDoubtfulAccountsReceivableCurrent Accounts Receivable, Allowance for Credit Loss, Current USD 9,000 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 15,000 2023-04-01 2023-09-30 2023 Q2 10-Q 2023-11-08 0001437749-23-030927
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 6,000 2016-04-01 2017-03-31 2017 FY 10-K 2017-06-22 0001437749-17-011716
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 0 2025-04-01 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap AssetRetirementObligation Asset Retirement Obligation USD 0 2025-03-31 2025 FY 10-K 2025-06-20 0001437749-25-020904
us-gaap Assets Assets USD 24.03M 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap AssetsCurrent Assets, Current USD 11.93M 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 41,000 2025-04-01 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap CapitalLeasedAssetsGross Capital Leased Assets, Gross USD 373,000 2018-03-31 2018 FY 10-K/A 2018-06-21 0001437749-18-012219
us-gaap CapitalLeaseObligations Capital Lease Obligations USD 98,000 2018-12-31 2019 Q3 10-Q 2019-02-13 0001437749-19-002456
us-gaap CapitalLeasesFutureMinimumPaymentsDue Capital Leases, Future Minimum Payments Due USD 7.81M 2016-03-31 2016 FY 10-K 2016-06-23 0001437749-16-034316
us-gaap CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation Capital Leases, Lessee Balance Sheet, Assets by Major Class, Accumulated Depreciation USD 175,000 2018-03-31 2018 FY 10-K/A 2018-06-21 0001437749-18-012219
us-gaap Cash Cash USD 840,000 2019-03-31 2020 Q3 10-Q 2020-02-11 0001437749-20-002306
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 649,000 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -78,000 2017-04-01 2018-03-31 2018 FY 10-K/A 2018-06-21 0001437749-18-012219
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 974,000 2023-03-31 2023 FY 10-K 2023-06-27 0001437749-23-018616
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 649,000 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 392,000 2025-04-01 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap CashUninsuredAmount Cash, Uninsured Amount USD 0 2025-03-31 2025 FY 10-K 2025-06-20 0001437749-25-020904
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.02 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 50.00M 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 7.39M 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 7.39M 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap CommonStockValue Common Stock, Value, Issued USD 148,000 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap ConstructionInProgressGross Construction in Progress, Gross USD 249,000 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 67,000 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized USD 42,000 2025-04-01 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 8.63M 2025-04-01 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap CostOfGoodsSold Cost of Goods Sold (Deprecated 2018-01-31) USD 14.55M 2017-04-01 2017-12-31 2018 Q3 10-Q 2018-02-06 0001437749-18-001823
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2024-04-01 2025-03-31 2025 FY 10-K 2025-06-20 0001437749-25-020904
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 8,000 2024-04-01 2025-03-31 2025 FY 10-K 2025-06-20 0001437749-25-020904
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 8,000 2024-04-01 2025-03-31 2025 FY 10-K 2025-06-20 0001437749-25-020904
us-gaap CustomerDepositsCurrent Customer Deposits, Current USD 83,000 2018-09-30 2019 Q2 10-Q 2018-11-13 0001437749-18-020377
us-gaap DebtCurrent Debt, Current USD 7.36M 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 0 2024-04-01 2025-03-31 2025 FY 10-K 2025-06-20 0001437749-25-020904
us-gaap DeferredFinanceCostsCurrentNet Debt Issuance Costs, Current, Net USD 74,000 2024-09-30 2024 Q2 10-Q 2024-11-12 0001437749-24-034529
us-gaap DeferredFinanceCostsNet Debt Issuance Costs, Net USD 62,000 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 0 2024-04-01 2025-03-31 2025 FY 10-K 2025-06-20 0001437749-25-020904
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 1.81M 2025-03-31 2025 FY 10-K 2025-06-20 0001437749-25-020904
us-gaap DeferredRentCreditNoncurrent Deferred Rent Credit, Noncurrent USD 43,000 2016-12-31 2017 Q3 10-Q 2017-02-07 0001437749-17-001860
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD 0 2024-04-01 2025-03-31 2025 FY 10-K 2025-06-20 0001437749-25-020904
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 7.02M 2025-03-31 2025 FY 10-K 2025-06-20 0001437749-25-020904
us-gaap DeferredTaxAssetsInventory Deferred Tax Assets, Inventory USD 107,000 2025-03-31 2025 FY 10-K 2025-06-20 0001437749-25-020904
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-03-31 2025 FY 10-K 2025-06-20 0001437749-25-020904
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 1.81M 2025-03-31 2025 FY 10-K 2025-06-20 0001437749-25-020904
us-gaap DeferredTaxAssetsNetCurrent Deferred Tax Assets, Net of Valuation Allowance, Current USD 157,000 2017-03-31 2018 FY 10-K/A 2018-06-21 0001437749-18-012219
us-gaap DeferredTaxAssetsNetNoncurrent Deferred Tax Assets, Net of Valuation Allowance, Noncurrent USD 3.04M 2015-03-31 2016 FY 10-K 2016-06-23 0001437749-16-034316
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 5.05M 2025-03-31 2025 FY 10-K 2025-06-20 0001437749-25-020904
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 11,000 2025-03-31 2025 FY 10-K 2025-06-20 0001437749-25-020904
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 20,000 2025-03-31 2025 FY 10-K 2025-06-20 0001437749-25-020904
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax Deferred Tax Assets, Tax Credit Carryforwards, Alternative Minimum Tax USD 148,000 2017-12-31 2018 Q3 10-Q 2018-02-06 0001437749-18-001823
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits USD 83,000 2025-03-31 2025 FY 10-K 2025-06-20 0001437749-25-020904
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 5.21M 2025-03-31 2025 FY 10-K 2025-06-20 0001437749-25-020904
us-gaap DeferredTaxLiabilitiesLeasingArrangements Deferred Tax Liabilities, Leasing Arrangements USD 1.06M 2025-03-31 2025 FY 10-K 2025-06-20 0001437749-25-020904
us-gaap DeferredTaxLiabilitiesNoncurrent Deferred Tax Liabilities, Net, Noncurrent USD 157,000 2017-03-31 2018 FY 10-K/A 2018-06-21 0001437749-18-012219
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 750,000 2025-03-31 2025 FY 10-K 2025-06-20 0001437749-25-020904
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 708,000 2025-04-01 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 708,000 2025-04-01 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap DilutiveSecurities Dilutive Securities, Effect on Basic Earnings Per Share USD 0 2021-04-01 2022-03-31 2024 FY 10-K 2024-06-26 0001437749-24-021266
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.13 2025-04-01 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares 0.15 2020-04-01 2021-03-31 2021 FY 10-K 2021-06-22 0001437749-21-015361
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.13 2025-04-01 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-04-01 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-04-01 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 180,400 2019-03-31 2018 FY 10-K 2019-07-01 0001437749-19-013217
us-gaap ExtinguishmentOfDebtGainLossNetOfTax Extinguishment of Debt, Gain (Loss), Net of Tax USD -51,000 2012-04-01 2013-03-31 2015 FY 10-K 2015-07-15 0001437749-15-013607
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments USD 0 2022-04-01 2023-03-31 2023 FY 10-K 2023-06-27 0001437749-23-018616
us-gaap GainLossOnDispositionOfAssets Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property USD -106,000 2017-04-01 2018-03-31 2020 FY 10-K 2020-06-23 0001437749-20-013699
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD -13,000 2025-04-01 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 0 2022-04-01 2023-03-31 2023 FY 10-K 2023-06-27 0001437749-23-018616
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 2.30M 2025-04-01 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap GrossProfit Gross Profit USD 4.17M 2025-04-01 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2016-04-01 2016-09-30 2017 Q2 10-Q 2016-11-10 0001437749-16-041673
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -925,000 2025-04-01 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD -1.21M 2016-04-01 2017-03-31 2017 FY 10-K 2017-06-22 0001437749-17-011716
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 0 2025-04-01 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2025-04-01 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability Income Tax Expense (Benefit), Continuing Operations, Adjustment of Deferred Tax (Asset) Liability USD 1.20M 2018-04-01 2019-03-31 2020 FY 10-K 2020-06-23 0001437749-20-013699
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 814,000 2024-04-01 2025-03-31 2025 FY 10-K 2025-06-20 0001437749-25-020904
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 0 2021-04-01 2022-03-31 2022 FY 10-K 2022-06-22 0001437749-22-015612
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -866,000 2024-04-01 2025-03-31 2025 FY 10-K 2025-06-20 0001437749-25-020904
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 30,000 2024-04-01 2025-03-31 2025 FY 10-K 2025-06-20 0001437749-25-020904
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 13,000 2024-04-01 2025-03-31 2025 FY 10-K 2025-06-20 0001437749-25-020904
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 6,000 2024-04-01 2025-03-31 2025 FY 10-K 2025-06-20 0001437749-25-020904
us-gaap IncomeTaxReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Amount USD 0 2021-04-01 2022-03-31 2022 FY 10-K 2022-06-22 0001437749-22-015612
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 24,000 2013-04-01 2014-03-31 2016 FY 10-K 2016-06-23 0001437749-16-034316
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 748,000 2025-04-01 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 394,000 2025-04-01 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 205,000 2025-04-01 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD -43,000 2025-04-01 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap IncreaseDecreaseInCustomerDeposits Increase (Decrease) in Customer Deposits USD -50,000 2018-04-01 2018-09-30 2019 Q2 10-Q 2018-11-13 0001437749-18-020377
us-gaap IncreaseDecreaseInDeferredLiabilities Increase (Decrease) in Deferred Liabilities USD -3,000 2023-04-01 2023-06-30 2023 Q1 10-Q 2023-08-11 0001437749-23-023314
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 604,000 2025-04-01 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -272,000 2025-04-01 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap IncreaseDecreaseInOtherCurrentAssets Increase (Decrease) in Other Current Assets USD -149,000 2016-04-01 2016-12-31 2017 Q3 10-Q 2017-02-07 0001437749-17-001860
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD -46,000 2018-04-01 2018-12-31 2019 Q3 10-Q 2019-02-13 0001437749-19-002456
us-gaap IncreaseDecreaseInOtherOperatingLiabilities Increase (Decrease) in Other Operating Liabilities USD 0 2024-04-01 2025-03-31 2025 FY 10-K 2025-06-20 0001437749-25-020904
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 3,000 2025-04-01 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap IncreaseDecreaseInRestrictedCash Increase (Decrease) in Restricted Cash USD 65,000 2017-04-01 2017-12-31 2019 Q3 10-Q 2019-02-13 0001437749-19-002456
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 70,000 2016-07-01 2016-09-30 2017 Q2 10-Q 2016-11-10 0001437749-16-041673
us-gaap InterestCostsCapitalized Interest Costs Capitalized USD 0 2017-04-01 2018-03-31 2018 FY 10-K/A 2018-06-21 0001437749-18-012219
us-gaap InterestExpense Interest Expense USD 361,000 2025-04-01 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap InterestIncomeExpenseNonoperatingNet Interest Income (Expense), Nonoperating, Net USD -582,000 2018-04-01 2019-03-31 2018 FY 10-K 2019-07-01 0001437749-19-013217
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 210,000 2017-04-01 2017-09-30 2018 Q2 10-Q 2017-11-06 0001437749-17-018407
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 360,000 2025-04-01 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap InterestPayableCurrent Interest Payable, Current USD 36,000 2015-12-31 2016 Q3 10-Q 2016-02-11 0001437749-16-025180
us-gaap InventoryFinishedGoodsNetOfReserves Inventory, Finished Goods, Net of Reserves USD 4.29M 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap InventoryNet Inventory, Net USD 8.38M 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap InventoryRawMaterialsNetOfReserves Inventory, Raw Materials, Net of Reserves USD 749,000 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap InventorySuppliesNetOfReserves Inventory, Supplies, Net of Reserves USD 249,000 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap InventoryValuationReserves Inventory Valuation Reserves USD 5,000 2018-03-31 2018 FY 10-K/A 2018-06-21 0001437749-18-012219
us-gaap InventoryWorkInProcessNetOfReserves Inventory, Work in Process, Net of Reserves USD 3.09M 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap InventoryWriteDown Inventory Write-down USD -10,000 2012-04-01 2013-03-31 2015 FY 10-K 2015-07-15 0001437749-15-013607
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 4.88M 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 2.12M 2025-03-31 2025 FY 10-K 2025-06-20 0001437749-25-020904
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 831,000 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 364,000 2025-03-31 2025 FY 10-K 2025-06-20 0001437749-25-020904
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 364,000 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 395,000 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 524,000 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 411,000 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 1.23M 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap Liabilities Liabilities USD 15.96M 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 24.03M 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap LiabilitiesCurrent Liabilities, Current USD 11.89M 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap LineOfCredit Long-term Line of Credit USD 2.00M 2019-03-31 2018 FY 10-K 2019-07-01 0001437749-19-013217
us-gaap LineOfCreditFacilityMaximumBorrowingCapacity Line of Credit Facility, Maximum Borrowing Capacity USD 2.00M 2020-06-30 2021 Q1 10-Q 2020-08-11 0001437749-20-017511
us-gaap LinesOfCreditCurrent Line of Credit, Current USD 0 2024-03-31 2024 FY 10-K 2024-06-26 0001437749-24-021266
us-gaap LongTermDebt Long-term Debt USD 4.22M 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap LongTermDebtAndCapitalLeaseObligations Long-term Debt and Lease Obligation USD 5.37M 2019-03-31 2018 FY 10-K 2019-07-01 0001437749-19-013217
us-gaap LongTermDebtAndCapitalLeaseObligationsCurrent Long-term Debt and Lease Obligation, Current USD 663,000 2019-03-31 2018 FY 10-K 2019-07-01 0001437749-19-013217
us-gaap LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities Long-term Debt and Lease Obligation, Including Current Maturities USD 7.05M 2019-12-31 2020 Q3 10-Q 2020-02-11 0001437749-20-002306
us-gaap LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal after Year Five USD 3.15M 2019-12-31 2020 Q3 10-Q 2020-02-11 0001437749-20-002306
us-gaap LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Five USD 301,000 2019-12-31 2020 Q3 10-Q 2020-02-11 0001437749-20-002306
us-gaap LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Four USD 491,000 2019-12-31 2020 Q3 10-Q 2020-02-11 0001437749-20-002306
us-gaap LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Three USD 2.23M 2019-12-31 2020 Q3 10-Q 2020-02-11 0001437749-20-002306
us-gaap LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Two USD 702,000 2019-12-31 2020 Q3 10-Q 2020-02-11 0001437749-20-002306
us-gaap LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal Remainder of Fiscal Year USD 177,000 2019-12-31 2020 Q3 10-Q 2020-02-11 0001437749-20-002306
us-gaap LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths Long-term Debt and Capital Lease Obligations, Repayments of Principal in Next Twelve Months USD 663,000 2019-03-31 2018 FY 10-K 2019-07-01 0001437749-19-013217
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 2.89M 2025-03-31 2025 FY 10-K 2025-06-20 0001437749-25-020904
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive Long-Term Debt, Maturity, after Year Five USD 2.20M 2022-03-31 2022 FY 10-K 2022-06-22 0001437749-22-015612
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths Long-term Debt, Maturities, Repayments of Principal in Next Rolling Twelve Months USD 202,000 2013-12-31 2013 Q3 10-Q 2014-02-06 0001104659-14-007141
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 0 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive Long-term Debt, Maturities, Repayments of Principal in Rolling after Year Five USD 4.48M 2013-12-31 2013 Q3 10-Q 2014-02-06 0001104659-14-007141
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive Long-term Debt, Maturities, Repayments of Principal in Rolling Year Five USD 214,000 2013-12-31 2013 Q3 10-Q 2014-02-06 0001104659-14-007141
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour Long-term Debt, Maturities, Repayments of Principal in Rolling Year Four USD 203,000 2013-12-31 2013 Q3 10-Q 2014-02-06 0001104659-14-007141
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree Long-term Debt, Maturities, Repayments of Principal in Rolling Year Three USD 199,000 2013-12-31 2013 Q3 10-Q 2014-02-06 0001104659-14-007141
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo Long-term Debt, Maturities, Repayments of Principal in Rolling Year Two USD 205,000 2013-12-31 2013 Q3 10-Q 2014-02-06 0001104659-14-007141
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive Long-Term Debt, Maturity, Year Five USD 339,000 2022-03-31 2022 FY 10-K 2022-06-22 0001437749-22-015612
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour Long-Term Debt, Maturity, Year Four USD 332,000 2022-12-31 2023 Q3 10-Q 2023-02-09 0001437749-23-002878
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree Long-Term Debt, Maturity, Year Three USD 1.00M 2025-03-31 2025 FY 10-K 2025-06-20 0001437749-25-020904
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 1.00M 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear Long-Term Debt, Maturity, Remainder of Fiscal Year USD 3.22M 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 1.00M 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap LongTermPurchaseCommitmentAmount Long-term Purchase Commitment, Amount USD 3.22M 2012-09-11 2012-09-12 2016 Q1 10-Q 2015-08-07 0001437749-15-015221
us-gaap NetCashProvidedByUsedInContinuingOperations Net Cash Provided by (Used in) Continuing Operations USD 695,000 2017-04-01 2017-09-30 2018 Q2 10-Q 2017-11-06 0001437749-17-018407
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 698,000 2025-04-01 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD -415,000 2017-04-01 2017-09-30 2018 Q2 10-Q 2017-11-06 0001437749-17-018407
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -86,000 2025-04-01 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -281,000 2017-04-01 2017-09-30 2018 Q2 10-Q 2017-11-06 0001437749-17-018407
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -220,000 2025-04-01 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD 1.39M 2017-04-01 2017-09-30 2018 Q2 10-Q 2017-11-06 0001437749-17-018407
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -925,000 2025-04-01 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap NetIncomeLossAttributableToParentDiluted Net Income (Loss) Attributable to Parent, Diluted USD 2.15M 2021-04-01 2022-03-31 2024 FY 10-K 2024-06-26 0001437749-24-021266
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD 99,000 2016-07-01 2016-09-30 2017 Q2 10-Q 2016-11-10 0001437749-16-041673
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD 99,000 2016-07-01 2016-09-30 2017 Q2 10-Q 2016-11-10 0001437749-16-041673
us-gaap NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1 Noncash or Part Noncash Acquisition, Value of Assets Acquired USD 495,000 2018-04-01 2019-03-31 2021 FY 10-K 2021-06-22 0001437749-21-015361
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD -502,000 2022-04-01 2023-03-31 2023 FY 10-K 2023-06-27 0001437749-23-018616
us-gaap NotesPayableCurrent Notes Payable, Current USD 600,000 2016-06-30 2017 Q1 10-Q 2016-08-15 0001437749-16-037433
us-gaap NumberOfOperatingSegments Number of Operating Segments pure 1 2025-04-01 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap NumberOfReportableSegments Number of Reportable Segments pure 1 2025-04-01 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap OperatingExpenses Operating Expenses USD 4.73M 2025-04-01 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -564,000 2025-04-01 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap OperatingLeaseCost Operating Lease, Cost USD 408,000 2025-04-01 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 702,000 2024-04-01 2025-03-31 2025 FY 10-K 2025-06-20 0001437749-25-020904
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 3.65M 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 576,000 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 3.07M 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 3.63M 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 269,000 2025-04-01 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 6.57M 2019-03-31 2018 FY 10-K 2019-07-01 0001437749-19-013217
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 567,000 2019-03-31 2018 FY 10-K 2019-07-01 0001437749-19-013217
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 336,000 2019-03-31 2018 FY 10-K 2019-07-01 0001437749-19-013217
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 493,000 2019-03-31 2018 FY 10-K 2019-07-01 0001437749-19-013217
us-gaap OperatingLeasesFutureMinimumPaymentsDueInRollingAfterYearFive Operating Leases, Future Minimum Payments, Due in Rolling after Year Five USD 5.09M 2013-12-31 2013 Q3 10-Q 2014-02-06 0001104659-14-007141
us-gaap OperatingLeasesFutureMinimumPaymentsDueInRollingYearFive Operating Leases, Future Minimum Payments, Due in Rolling Year Five USD 299,000 2013-12-31 2013 Q3 10-Q 2014-02-06 0001104659-14-007141
us-gaap OperatingLeasesFutureMinimumPaymentsDueInRollingYearFour Operating Leases, Future Minimum Payments, Due in Rolling Year Four USD 305,000 2013-12-31 2013 Q3 10-Q 2014-02-06 0001104659-14-007141
us-gaap OperatingLeasesFutureMinimumPaymentsDueInRollingYearThree Operating Leases, Future Minimum Payments, Due in Rolling Year Three USD 341,000 2013-12-31 2013 Q3 10-Q 2014-02-06 0001104659-14-007141
us-gaap OperatingLeasesFutureMinimumPaymentsDueInRollingYearTwo Operating Leases, Future Minimum Payments, Due in Rolling Year Two USD 442,000 2013-12-31 2013 Q3 10-Q 2014-02-06 0001104659-14-007141
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 572,000 2019-03-31 2018 FY 10-K 2019-07-01 0001437749-19-013217
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 573,000 2019-03-31 2018 FY 10-K 2019-07-01 0001437749-19-013217
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 4.03M 2019-03-31 2018 FY 10-K 2019-07-01 0001437749-19-013217
us-gaap OperatingLeasesFutureMinimumPaymentsNextRollingTwelveMonths Operating Leases, Future Minimum Payments, Next Rolling Twelve Months USD 482,000 2013-12-31 2013 Q3 10-Q 2014-02-06 0001104659-14-007141
us-gaap OperatingLeasesRentExpenseContingentRentals Operating Leases, Rent Expense, Contingent Rentals USD 54,000 2018-04-01 2019-03-31 2018 FY 10-K 2019-07-01 0001437749-19-013217
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 588,000 2018-04-01 2019-03-31 2018 FY 10-K 2019-07-01 0001437749-19-013217
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.074 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 19.22M 2025-03-31 2025 FY 10-K 2025-06-20 0001437749-25-020904
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 99,000 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 111,000 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 0 2024-03-31 2024 FY 10-K 2024-06-26 0001437749-24-021266
us-gaap OtherLongTermDebtNoncurrent Other Long-term Debt, Noncurrent USD 57,000 2019-03-31 2018 FY 10-K 2019-07-01 0001437749-19-013217
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 5,000 2011-04-01 2012-03-31 2012 FY 10-K 2013-06-24 0001104659-13-051049
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 5,000 2011-04-01 2012-03-31 2014 FY 10-K 2014-06-27 0001437749-14-011994
us-gaap PaymentsForCapitalImprovements Payments for Capital Improvements USD 86,000 2025-04-01 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD -94,000 2015-04-01 2015-09-30 2017 Q2 10-Q 2016-11-10 0001437749-16-041673
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 3,000 2025-04-01 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap PaymentsToAcquireBuildings Payments to Acquire Buildings USD 100,000 2018-04-01 2019-03-31 2021 FY 10-K 2021-06-22 0001437749-21-015361
us-gaap PaymentsToAcquireProductiveAssets Payments to Acquire Productive Assets USD 86,000 2019-04-01 2019-09-30 2020 Q2 10-Q 2019-11-12 0001437749-19-022447
us-gaap PostemploymentBenefitsLiabilityCurrent Postemployment Benefits Liability, Current USD 68,000 2019-12-31 2020 Q3 10-Q 2020-02-11 0001437749-20-002306
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.01 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 550,000 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 35,000 2025-04-01 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 166,000 2017-04-01 2018-03-31 2020 FY 10-K 2020-06-23 0001437749-20-013699
us-gaap ProceedsFromIssuanceOfUnsecuredDebt Proceeds from Issuance of Unsecured Debt USD 0 2022-04-01 2023-03-31 2023 FY 10-K 2023-06-27 0001437749-23-018616
us-gaap ProceedsFromLinesOfCredit Proceeds from Lines of Credit USD 611,000 2016-04-01 2016-12-31 2017 Q3 10-Q 2017-02-07 0001437749-17-001860
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 600,000 2016-04-01 2017-03-31 2018 FY 10-K 2019-07-01 0001437749-19-013217
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 1.50M 2019-04-01 2020-03-31 2021 FY 10-K 2021-06-22 0001437749-21-015361
us-gaap ProceedsFromRepaymentsOfLinesOfCredit Proceeds from (Repayments of) Lines of Credit USD -180,000 2023-04-01 2023-12-31 2023 Q3 10-Q 2024-02-08 0001437749-24-003511
us-gaap ProceedsFromRepaymentsOfRelatedPartyDebt Proceeds from (Repayments of) Related Party Debt USD 0 2023-04-01 2024-03-31 2024 FY 10-K 2024-06-26 0001437749-24-021266
us-gaap ProceedsFromShortTermDebt Proceeds from Short-term Debt USD 1.20M 2025-04-01 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 4,000 2019-04-01 2019-12-31 2021 Q3 10-Q 2021-02-11 0001437749-21-002584
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD 486,000 2011-04-01 2011-06-30 2011 Q1 10-Q 2011-08-11 0001104659-11-046124
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 37.66M 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 8.35M 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap ProvisionForDoubtfulAccounts Accounts Receivable, Credit Loss Expense (Reversal) USD -7,000 2025-04-01 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap PurchaseObligation Purchase Obligation USD 1.22M 2025-03-31 2025 FY 10-K 2025-06-20 0001437749-25-020904
us-gaap RepaymentsOfLinesOfCredit Repayments of Lines of Credit USD 1.00M 2021-04-01 2021-12-31 2022 Q3 10-Q 2022-02-10 0001437749-22-002997
us-gaap RepaymentsOfLongTermCapitalLeaseObligations Repayments of Long-term Capital Lease Obligations USD 9,000 2020-04-01 2020-06-30 2021 Q1 10-Q 2020-08-11 0001437749-20-017511
us-gaap RepaymentsOfLongTermDebt Repayments of Long-term Debt USD 670,000 2020-04-01 2021-03-31 2021 FY 10-K 2021-06-22 0001437749-21-015361
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 500,000 2015-09-18 2023 Q2 10-Q 2022-11-09 0001437749-22-026580
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 0 2022-04-01 2022-12-31 2023 Q3 10-Q 2023-02-09 0001437749-23-002878
us-gaap RepaymentsOfSecuredDebt Repayments of Secured Debt USD 144,000 2025-04-01 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap RepaymentsOfShortTermDebt Repayments of Short-term Debt USD 390,000 2025-04-01 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 152,000 2025-04-01 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 65,000 2018-03-31 2020 FY 10-K 2020-06-23 0001437749-20-013699
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 65,000 2018-03-31 2018 FY 10-K 2019-07-01 0001437749-19-013217
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -27.03M 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 12.80M 2025-04-01 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap RevenueFromContractWithCustomerIncludingAssessedTax Revenue from Contract with Customer, Including Assessed Tax USD 32.34M 2020-04-01 2021-03-31 2021 FY 10-K 2021-06-22 0001437749-21-015361
us-gaap Revenues Revenues USD 34.12M 2017-04-01 2018-03-31 2018 FY 10-K/A 2018-06-21 0001437749-18-012219
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 18,000 2024-04-01 2025-03-31 2025 FY 10-K 2025-06-20 0001437749-25-020904
us-gaap SalesAndExciseTaxPayableCurrent Sales and Excise Tax Payable, Current USD 140,000 2016-03-31 2017 FY 10-K 2017-06-22 0001437749-17-011716
us-gaap SalesRevenueGoodsNetPercentage Sales Revenue, Goods, Net, Percentage (Deprecated 2013-01-31) pure 1 2013-03-31 2012 FY 10-K 2013-06-24 0001104659-13-051049
us-gaap SalesRevenueNet Revenue, Net (Deprecated 2018-01-31) USD 26.01M 2017-04-01 2017-12-31 2018 Q3 10-Q 2018-02-06 0001437749-18-001823
us-gaap SellingAndMarketingExpense Selling and Marketing Expense USD 2.28M 2025-04-01 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 74,000 2025-04-01 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 422,988 2020-12-31 2021 Q3 10-Q 2021-02-11 0001437749-21-002584
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value USD 99,000 2023-04-01 2024-03-31 2024 FY 10-K 2024-06-26 0001437749-24-021266
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price USD/shares 0.78 2025-03-31 2025 FY 10-K 2025-06-20 0001437749-25-020904
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2024-04-01 2025-03-31 2025 FY 10-K 2025-06-20 0001437749-25-020904
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0 2024-04-01 2025-03-31 2025 FY 10-K 2025-06-20 0001437749-25-020904
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 0.64 2014-04-01 2014-09-30 2015 Q2 10-Q 2014-11-13 0001437749-14-020667
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.036 2024-04-01 2025-03-31 2025 FY 10-K 2025-06-20 0001437749-25-020904
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.017 2014-04-01 2014-09-30 2015 Q2 10-Q 2014-11-13 0001437749-14-020667
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized shares 2.10M 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 546,882 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 0 2025-03-31 2025 FY 10-K 2025-06-20 0001437749-25-020904
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 255,334 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 2.57 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 0 2024-04-01 2025-03-31 2025 FY 10-K 2025-06-20 0001437749-25-020904
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 25,000 2024-04-01 2025-03-31 2025 FY 10-K 2025-06-20 0001437749-25-020904
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 17,220 2014-04-01 2014-09-30 2015 Q2 10-Q 2014-11-13 0001437749-14-020667
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 4.48 2014-04-01 2014-09-30 2015 Q2 10-Q 2014-11-13 0001437749-14-020667
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 50,000 2025-04-01 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 475,000 2025-04-01 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 0.19 2025-04-01 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares shares 491,666 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares shares 50,000 2025-04-01 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value USD/shares 0.15 2025-04-01 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price USD/shares 0.2 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 10,325 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 747,000 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 1.11 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 8,539 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 640,687 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 1.24 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 96,000 2024-04-01 2025-03-31 2025 FY 10-K 2025-06-20 0001437749-25-020904
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares shares 33,334 2025-04-01 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value USD/shares 0.97 2025-04-01 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 3.59 2020-04-01 2021-03-31 2023 FY 10-K 2023-06-27 0001437749-23-018616
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 2.57 2024-04-01 2025-03-31 2025 FY 10-K 2025-06-20 0001437749-25-020904
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 0.78 2025-04-01 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 0.34 2025-04-01 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price USD/shares 2.64 2025-03-31 2025 FY 10-K 2025-06-20 0001437749-25-020904
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable shares 222,000 2025-03-31 2025 FY 10-K 2025-06-20 0001437749-25-020904
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding shares 322,000 2025-03-31 2025 FY 10-K 2025-06-20 0001437749-25-020904
us-gaap SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price USD/shares 2.2 2025-03-31 2025 FY 10-K 2025-06-20 0001437749-25-020904
us-gaap SharePrice Share Price USD/shares 0.3 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap ShortTermBorrowings Short-term Debt USD 370,000 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap ShortTermNonBankLoansAndNotesPayable Short-term Non-bank Loans and Notes Payable USD 38,000 2020-03-31 2021 FY 10-K 2021-06-22 0001437749-21-015361
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 8.06M 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD 11.65M 2011-06-30 2011 Q1 10-Q 2011-08-11 0001104659-11-046124
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 19,000 2020-04-01 2021-03-31 2023 FY 10-K 2023-06-27 0001437749-23-018616
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 10,000 2024-04-01 2024-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardGross Stock Issued During Period, Value, Restricted Stock Award, Gross USD 7,000 2025-04-01 2025-06-30 2025 Q1 10-Q 2025-08-06 0001437749-25-025070
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures USD -7,000 2025-04-01 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 68,000 2020-04-01 2021-03-31 2023 FY 10-K 2023-06-27 0001437749-23-018616
us-gaap TaxCreditCarryforwardAmount Tax Credit Carryforward, Amount USD 28,000 2020-03-31 2020 FY 10-K 2020-06-23 0001437749-20-013699
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2025-06-30 2025 Q1 10-Q 2025-08-06 0001437749-25-025070
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2025-03-31 2025 FY 10-K 2025-06-20 0001437749-25-020904
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD -158,000 2016-04-01 2017-03-31 2017 FY 10-K 2017-06-22 0001437749-17-011716
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 11 2021-04-01 2022-03-31 2024 FY 10-K 2024-06-26 0001437749-24-021266
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 7.25M 2025-04-01 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 5.82M 2018-04-01 2019-03-31 2021 FY 10-K 2021-06-22 0001437749-21-015361
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 7.25M 2025-04-01 2025-09-30 2025 Q2 10-Q 2025-11-10 0001437749-25-034093

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →